Recurrent transient global amnesia with intrathecal baclofen

Anesthesia and Analgesia

Volumn 106, Issue 4, 2008, Pages 1284-1287

  Grande, Lucinda A ^a   Loeser, John D ^a   Samii, Ali ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; FLUDROCORTISONE; GABAPENTIN; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; TIZANIDINE; TOPIRAMATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DOSE RESPONSE; DYSTONIA; FEMALE; HUMAN; HYPOTENSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSIENT GLOBAL AMNESIA;

EID: 41349106239     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318165e1c6     Document Type: Article

References (31)

1. Package Insert: Lioresal(R) Intrathecal (baclofen injection). Minneapolis, MN: Medtronic, Inc., 2002
2. Albright AL, Barry MJ, Shafton DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001;43:652-7
3. Lee TH, Chen SS, Su SL, Yang SS. Baclofen intoxication: report of four cases and review of the literature. Clin Neuropharmacol 1992;15:56-62
4. Sandyk R, Gillman MA. Baclofen-induced memory impairment. Clin Neuropharmacol 1985;8:294-5
5. Caplan LR. Transient global amnesia. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology. Amsterdam: Elsevier Science Publishers, 1985;45:205-18
6. Sander K, Sander D. New Insights into transient global amnesia: recent imaging and clinical findings. Lancet Neurol 2005;4:437-44
7. Fisher CM, Adams RD. Transient global amnesia. Trans Amer Neurol Assoc 1958;83:143-6
8. Miller JW, Petersen RC, Metter EJ, Millikan CH, Yanagihara T. Transient global amnesia: clinical characteristics and prognosis. Neurology 1987;37:733-7
9. Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry 1990;53:834-43
10. Nakagawa Y, Takashima T. The GABA-B receptor antagonist CGP36742 attenuates the baclofen- and scopolamine-induced deficits in Morris water maze task in rats. Brain Res 1997;766:101-6
11. Hampson RE, Deadwyler SA. Temporal firing characteristics and the strategic role of subicular neurons in short-term memory. Hippocampus 2003;13:529-41
12. Pitsikas N, Rigamonti AE, Cella SG, Muller EE. The GABA-B receptor and recognition memory: possible modulation of its behavioral effects by the nitrergic system. Neuroscience 2003;118:1121-7
13. Lei S, McBain CJ. GABA-B receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons. J Physiol 2002;546:439-53
14. Stackman RW, Walsh TJ. Baclofen produces dose-related working memory impairments after intraseptal injection. Behav Neural Biol 1994;61:181-5
15. Moncada S, Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12
16. Chowdhary S, Townend JN. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin Sci 1999;97:5-17
17. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature (London) 1988;336:385-8
18. Haley JE, Wilcox GL, Chapman PF. The role of nitric oxide in hippocampal long-term potentiation. Neuron 1992;8:211-6
19. Fin C, Da Cunha C, Bromberg E, Schmitz PK, Bianchin M, Medina JH, Izquierdo I. Experiments suggesting a role for nitric oxide in the hippocampus in memory processes. Neurobiol Learn Mem 1995;63:113-5
20. Meyer RC, Spangler EL, Patel N, London ED, Ingram DK. Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur J Pharmacol 1998;341:17-22
21. Product Information: Isordil(R), isosorbide dinitrate. Philadelphia, PA: Wyeth-Ayerst Laboratories, 1996
22. Guevara-Guzman R, Emson PC, Kendrick KM. Modulation of in vivo transmitter release by nitric oxide and cyclic GMP. J Neurochem 1994;62:807-10
23. Jones NM, Loiacono RE, Moller M, Beart PM. Diverse roles for nitric oxide in synaptic signaling after activation of NMDA release regulating receptors. Neuropharmacology 1994;33:1351- 6
24. Getting SJ, Segieth J, Ahmad S, Biggs CS, Whitton PS. Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Res 1996;717:196-9
25. Segieth J, Getting SJ, Biggs CS, Whitton PS. Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats. Neurosci Lett 1995;170:101-4
26. Segovia G, Mora F. Role of nitric oxide in modulating the release of dopamine, glutamate and GABA in striatum of the freely moving rat. Brain Res Bull 1998;45:275-9
27. Wright JW, Harding JW. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning and memory. Prog Neurobiol 2004;72:263-93
28. Lee EH, Ma YL, Wayner MJ, Armstrong DL. Impaired retention by angiotensin II mediated by the AT1 receptor. Peptides 1995;16:1069-71
29. Krizanova O, Kiss A, Zacikova L, Jezova D. Nitric oxide synthase mRNA levels correlate with gene expression of Angiotensin II type-1 but not type-2 receptors, renin or angiotensin converting enzyme in selected brain areas. Physiol Res 2001;50:473-80
30. Meuli-Simmen C, Liu Y, Yeo TT, Liggitt D, Guanghuan T Yang T, Meuli M, Knauer S, Heath TD, Long FM, Debs RJ. Gene expression along the cerebral-spinal axis after regional gene delivery. Hum Gene Ther 1999;10:2689-700
31. Kulik A, Vida I, Lujan R, Haas CA, Lopez-Bendito G, Shigemoto R, Frotscher M. Subcellular localization of metabotropic GABA-B receptor subunits GABA-B1a/b and GABA-B2 in the rat hippocampus. J Neurosci 2003;23:11026-35